The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Development of a geriatric vulnerability score (GVS) in elderly advanced ovarian cancer (AOC) patients (pts) treated in first line: A prospective GINECO trial.
Gilles Freyer
No relevant relationships to disclose
Beatrice E. Weber
No relevant relationships to disclose
Daniela Lebrun-Jezekova
No relevant relationships to disclose
Fabien Tinquaut
No relevant relationships to disclose
Olivier Tredan
Research Funding - Roche
Emmanuel Sevin
No relevant relationships to disclose
Laetitia Stefani
No relevant relationships to disclose
Eric Pujade-Lauraine
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Claire Falandry
No relevant relationships to disclose